PDPN-expressing cancer cells have enhanced malignant potential due to enhancement of platelet aggregation, which promotes metastasis [24,25], alteration of cell morphology and motility [26,27], and epithelial-mesenchymal transition [28]. Here, PDPN is linked to cancer.